The conference will include 3 tracks:
Plenary presentations from leaders in the field
Daily Working Group Updates and Discussion Sessions on Precision Medicine for:
Short Oral Presentations (E-posters) with mentored discussions, with focus on early career participants, mentorship and meet-the-professor sessions
Each day of the virtual conference will include a series of plenary talks from key stakeholders and experts in various aspects of precision diabetes medicine, followed by a featured keynote talk from an individual living with diabetes. The Virtual Poster Hall will be open during the entirety of the virtual event to showcase scientific efforts in the field.
| Day 1 (8:00-10:00 EST): Vision and Direction of the Precision Medicine for Diabetes Initiative |
|
Welcome and opening remarks Tracey Brown, CEO, American Diabetes Association |
|
Opening remarks Stefano Del Prato, President, European Association for the Study of Diabetes |
|
Keynote: The Precision Medicine in Diabetes Initiative – Treating the Whole Person Robert Gabbay, Chief Scientific and Medical Officer, American Diabetes Association |
|
Keynote: Real Life Needs of People with Diabetes. Dana Lewis, US, living with type 1 diabetes |
|
Precision Medicine and the Research Agenda for Diabetes William Cefalu, Director, Division of Diabetes, Endocrinology and Metabolic Disease, NIDDK |
|
The Precision Medicine in Diabetes Initiative – Vision and Future Direction Paul Franks, Co-Chair, Lund University Diabetes Center, Sweden |
|
A Vision for Future Diabetes Care based on Precision. Martin Ridderstråle, Senior Vice President and Head of Patient Care, Novo Nordisk Foundation |
| Day 2 (9:00-11:30 EST): Clinical and Scientific Challenges and Opportunities for Precision Diabetes Medicine |
|
Keynote: Personalizing Diabetes Care in 2021 John Buse, Chief, Division of Endocrinology, University of North Carolina at Chapel Hill |
|
Keynote: Living and staying healthy with type 2 diabetes Adithya Menon, India, living with type 2 diabetes |
|
Precision Diabetes in South Asians V Mohan, Chair, Dr Mohan’s Diabetes Specialties Centre, Chennai, India |
|
Sub-classification of diabetes: Possibilities and Challenges. Miriam Udler, Massachusetts General Hospital and Broad Institute, Boston, US |
|
Precision Approach to Diabetes in Pregnancy Marie-France Hivert, Dept of Population Medicine, Harvard Medical School |
|
Approach to Precision Medicine for ‘Common’ Type 2 diabetes Chris Rhodes, Chief Scientist, Cardiovascular, Renal and Metabolism, Astra Zeneca, Gaithersburg, MD, US |
|
Precision Prevention of Type 1 Diabetes Jessica Dunne, Janssen Pharmaceuticals, New Jersey, US |
| 11:10-11:30 Panel discussion |
| Day 3 (9:00-11:20 EST): From History to Future Policy— Broader Context for Precision Diabetes Medicine |
|
Keynote: Precision Diabetes Care – a historical perspective on race and disease Arleen Tuchman, Nelson O. Tyrone Jr. Professor of History, Vanderbilt University |
|
Keynote: The Importance of the Diagnosis Kristin Skiados, living with monogenic diabetes |
|
Precision Monitoring and Technology in Diabetes Care David Klonoff, Director, Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California |
|
Precision Monitoring – Approach to Policy Implementation Dirk Mueller-Wieland, Head Clinical Research Centre, Dept of Medicine, University of Aachen, Germany |
|
Public-private partnerships in the research approach to Precision Medicine Bernd Stowasser, Sanofi, IMI Strategic Governance Group, Diabetes & Metabolic Disorders |
|
The Accelerating Medicines Partnership in Type 2 Diabetes. Philip Smith, Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK |
|
Thoughts on Precision Medicine in Diabetes: an Industry Perspective. Speaker: Rasmus Rabøl, Corporate Vice President, Clinical Pharmacology and Translational Medicine, Novo Nordisk |
| 11:10-11:20 Panel discussion, transition to Closing Remarks (11:20-11:30) |
